Literature DB >> 25955017

The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.

Noriko Yamamoto1, Rika Nishikawa1, Takeshi Chiyomaru2, Yusuke Goto1, Ichiro Fukumoto1, Hirokazu Usui3, Akira Mitsuhashi3, Hideki Enokida2, Masayuki Nakagawa2, Makio Shozu3, Naohiko Seki1.   

Abstract

In developed countries, endometrial cancer (EC) is the most common malignancy among women. Unopposed estrogen therapy, obesity, nulliparity, diabetes mellitus and arterial hypertension have been linked to an increased risk of EC. However, the molecular mechanisms of EC oncogenesis and metastasis have not yet been fully elucidated. Our recent studies of microRNA (miRNA) expression signatures revealed that the microRNA-1/133a (miR‑1/133a) cluster is frequently downregulated in various types of human cancers. However, the functional role of the miR‑1/133a cluster in EC cells is still unknown. Thus, the aim of this study was to investigate the functional significance of the miR‑1/133a cluster and its regulated molecular targets, with an emphasis on the contributions of miR‑1/133a to EC oncogenesis and metastasis. We found that the expression levels of miR‑1 and miR‑133a were significantly reduced in EC tissues. Moreover, restoration of mature miR‑1 or miR‑133a miRNAs significantly inhibited cancer cell migration and invasion, suggesting that these clustered miRNAs act as tumor suppressors. Prediction of miRNA targets revealed that phosphodiesterase 7A (PDE7A) was a potential target gene regulated by both miR‑1 and miR‑133a. PDE7A was confirmed to be overexpressed in EC clinical specimens and silencing of PDE7A significantly inhibited cancer cell migration and invasion. Our data demonstrated that downregulation of the miR‑1/133a cluster promoted cancer cell migration and invasion via overexpression of PDE7A in EC cells. Elucidation of the molecular networks regulated by tumor-suppressive miRNAs will provide insights into the molecular mechanisms of EC oncogenesis and metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25955017     DOI: 10.3892/ijo.2015.2986

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Altered microRNA expression patterns during the initiation and promotion stages of neonatal diethylstilbestrol-induced dysplasia/neoplasia in the hamster (Mesocricetus auratus) uterus.

Authors:  Ramesh Padmanabhan; Isabel R Hendry; Jennifer R Knapp; Bin Shuai; William J Hendry
Journal:  Cell Biol Toxicol       Date:  2017-03-06       Impact factor: 6.691

Review 2.  The Roles of MicroRNA-133 in Gynecological Tumors.

Authors:  Yang Zhou; Zhongping Cheng
Journal:  Gynecol Minim Invasive Ther       Date:  2022-05-04

3.  Therapeutically blocking Interleukin-11 Receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours.

Authors:  Amy Winship; Michelle Van Sinderen; Katarzyna Rainczuk; Evdokia Dimitriadis
Journal:  Oncotarget       Date:  2017-04-04

Review 4.  MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.

Authors:  San-Nung Chen; Renin Chang; Li-Te Lin; Chyi-Uei Chern; Hsiao-Wen Tsai; Zhi-Hong Wen; Yi-Han Li; Chia-Jung Li; Kuan-Hao Tsui
Journal:  Int J Environ Res Public Health       Date:  2019-04-29       Impact factor: 3.390

5.  Integrated Analysis of MicroRNA (miRNA) and mRNA Profiles Reveals Reduced Correlation between MicroRNA and Target Gene in Cancer.

Authors:  Xingsong Li; Xiaokang Yu; Yuting He; Yuhuan Meng; Jinsheng Liang; Lizhen Huang; Hongli Du; Xueping Wang; Wanli Liu
Journal:  Biomed Res Int       Date:  2018-12-06       Impact factor: 3.411

6.  miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma.

Authors:  Chuan He; Hongwei Chen; Yan Liu; Xiaolin Li; Chaoju Zhang; Qunyan Qin; Qixiong Pang
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

7.  A novel isoform of ATOH8 promotes the metastasis of breast cancer by regulating RhoC.

Authors:  Mengyao Xu; Shan Huang; Xiaoli Dong; Yanan Chen; Miao Li; Wen Shi; Guanwen Wang; Chongbiao Huang; Qiong Wang; Yanhua Liu; Peiqing Sun; Shuang Yang; Rong Xiang; Antao Chang
Journal:  J Mol Cell Biol       Date:  2021-04-10       Impact factor: 6.216

8.  Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma.

Authors:  Shunichi Asai; Ayaka Koma; Nijiro Nohata; Takashi Kinoshita; Naoko Kikkawa; Mayuko Kato; Chikashi Minemura; Katsuhiro Uzawa; Toyoyuki Hanazawa; Naohiko Seki
Journal:  Biomedicines       Date:  2022-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.